Worth reading
65In focus
Scored from 4 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
500000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Exercise status of the 16th stock acquisition rights issued through third-party allotment (with Exercise Price Adjustment Clause)
発行・処分する株式数
500,000 new shares (transferred treasury shares: 0)
Intended allottee
Macquarie Bank Limited (allottee at issuance)
Terms of the stock acquisition rights
Exercise price
¥17.0. The terms provide for adjustment to an amount equivalent to 92% of the closing price on the preceding business day. Floor: Not disclosed.
Number of Stock Acquisition Rights
Total issued: 50,000; exercised this time: 5,000; currently unexercised: 20,000
Basis for determining the amount to be paid
The exercise price is revised to an amount equivalent to 92% of the closing price on the business day preceding the date on which the company receives notice of each exercise request, with fractions of less than ¥1 rounded down. The exercise price on 6 October 2026 was ¥17.0.
Most recent equity financing
Timing 9 April 2025 / Type Issuance of Series 16 Stock Acquisition Rights (with an exercise price adjustment provision) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 16th stock acquisition rights issued through third-party allotment (with Exercise Price Adjustment Clause) |
| Number of shares to be issued or disposed of | 500,000 new shares (transferred treasury shares: 0) |
| Intended allottee | Macquarie Bank Limited (allottee at issuance) |
| Total number of issued shares | 297,121,340 shares (as of the end of the month preceding the month covered) → Not disclosed |
| Basis for determining the amount to be paid | The exercise price is revised to an amount equivalent to 92% of the closing price on the business day preceding the date on which the company receives notice of each exercise request, with fractions of less than ¥1 rounded down. The exercise price on 6 October 2026 was ¥17.0. |
| Exercise price | ¥17.0. The terms provide for adjustment to an amount equivalent to 92% of the closing price on the preceding business day. Floor: Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 50,000; exercised this time: 5,000; currently unexercised: 20,000 |
| Most recent equity financing | Timing 9 April 2025 / Type Issuance of Series 16 Stock Acquisition Rights (with an exercise price adjustment provision) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the bulk exercise of Series 16 Stock Acquisition Rights on 6 October 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.